BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38702437)

  • 21. Should Positive Cytology Revealed by Intraoperative Lavage Preclude Radical Resection in Resectable Pancreatic Cancer?: A Systemic Review and Meta-analysis.
    Li BQ; Wang HY; Li L; Jiang B; Ma CL; Yuan CH; Xiu DR
    Pancreas; 2022 Nov-Dec 01; 51(10):1263-1276. PubMed ID: 37099766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative Peritoneal Washing Cytology on Survival in Pancreatic Ductal Adenocarcinoma With Resectable, Locally Advanced, and Metastatic Disease.
    Yin Z; Ma T; Chen S
    Pancreas; 2019 Apr; 48(4):519-525. PubMed ID: 30946232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reappraisal of peritoneal washing cytology in 984 patients with pancreatic ductal adenocarcinoma who underwent margin-negative resection.
    Satoi S; Murakami Y; Motoi F; Uemura K; Kawai M; Kurata M; Sho M; Matsumoto I; Yanagimoto H; Yamamoto T; Mizuma M; Unno M; Hashimoto Y; Hirono S; Yamaue H; Honda G; Nagai M; Nakajima Y; Shinzeki M; Fukumoto T; Kwon AH
    J Gastrointest Surg; 2015 Jan; 19(1):6-14; discussion 14. PubMed ID: 25316482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative cytology for drained fluid from the pancreatic bed after "curative" resection of pancreatic cancers: does it predict both the patient's prognosis and the site of cancer recurrence?
    Ishikawa O; Wada H; Ohigashi H; Doki Y; Yokoyama S; Noura S; Yamada T; Sasaki Y; Imaoka S; Kasugai T; Matsunaga T; Takenaka A; Nakaizumi A
    Ann Surg; 2003 Jul; 238(1):103-10. PubMed ID: 12832972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
    Yamamoto K; Shimada S; Hirota M; Yagi Y; Matsuda M; Baba H
    Int J Oncol; 2005 Nov; 27(5):1321-8. PubMed ID: 16211228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative risk factors for positivity of peritoneal lavage cytology in patients with pancreatic ductal adenocarcinoma in the era of neoadjuvant therapy.
    Otsuka H; Uemura K; Kondo N; Sumiyoshi T; Okada K; Seo S; Murakami Y; Takahashi S
    Pancreatology; 2022 Jun; 22(5):583-589. PubMed ID: 35466060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of staging laparoscopy for resectable pancreatic cancer on imaging and the therapeutic effect of systemic chemotherapy for positive peritoneal cytology.
    Fukasawa M; Watanabe T; Tanaka H; Itoh A; Kimura N; Shibuya K; Yoshioka I; Murotani K; Hirabayashi K; Fujii T
    J Hepatobiliary Pancreat Sci; 2023 Nov; 30(11):1261-1272. PubMed ID: 37750024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishment of planned staging laparoscopy criteria.
    Tanaka N; Takami H; Hayashi M; Inokawa Y; Kurimoto K; Hattori N; Kanda M; Tanaka C; Nakayama G; Kodera Y
    J Hepatobiliary Pancreat Sci; 2023 Nov; 30(11):1273-1281. PubMed ID: 37799038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of intraperitoneal lavage cytology before colorectal cancer resection.
    Fujii S; Shimada H; Yamagishi S; Ota M; Kunisaki C; Ike H; Ichikawa Y
    Int J Colorectal Dis; 2009 Aug; 24(8):907-14. PubMed ID: 19475411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer.
    Pak LM; Coit DG; Eaton AA; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Strong VE; Kingham TP
    Ann Surg Oncol; 2017 May; 24(5):1174-1179. PubMed ID: 28058561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence.
    Sato K; Mori R; Hiroshima Y; Oba MS; Matsuyama R; Bouvet M; Hoffman RM; Endo I
    J Surg Res; 2018 Jun; 226():122-130. PubMed ID: 29661277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical importance of intraoperative peritoneal cytology in patients with pancreatic cancer.
    Abe T; Ohuchida K; Endo S; Ookubo F; Mori Y; Nakata K; Miyasaka Y; Manabe T; Ohtsuka T; Nagai E; Oda Y; Nakamura M
    Surgery; 2017 Apr; 161(4):951-958. PubMed ID: 27939334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail Cancer: A Retrospective Study.
    Mashiko T; Ogasawara T; Masuoka Y; Ei S; Takahashi S; Hirabayashi K; Mori M; Koyanagi K; Yamamoto S; Nakagohri T
    World J Surg; 2023 Mar; 47(3):729-739. PubMed ID: 36357802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of minute cancer cell dissemination in peritoneal lavage fluid detected by reverse transcription PCR is an independent prognostic factor in patients with resectable pancreatic cancer.
    Eguchi H; Ohigashi H; Takahashi H; Yano M; Motoori M; Miyashiro I; Kishi K; Ohue M; Noura S; Seki Y; Yamada T; Goto K; Yamamoto T; Idota A; Fujii J; Nakajima H; Yamasaki T; Ishikawa O
    Surgery; 2009 Nov; 146(5):888-95. PubMed ID: 19744431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical role of staging laparoscopy in patients with radiographically defined locally advanced pancreatic ductal adenocarcinoma.
    Satoi S; Yanagimoto H; Yamamoto T; Toyokawa H; Hirooka S; Yamaki S; Opendro SS; Inoue K; Michiura T; Ryota H; Matsui Y; Kon M
    World J Surg Oncol; 2016 Jan; 14(1):14. PubMed ID: 26791083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy.
    Hata T; Mizuma M; Masuda K; Chiba K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Kamei T; Unno M
    Ann Surg Oncol; 2021 Apr; 28(4):2235-2245. PubMed ID: 33393045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival and the prognosticators of peritoneal cytology-positive pancreatic cancer patients undergoing curative resection followed by adjuvant chemotherapy.
    Aoyama T; Atsumi Y; Kazama K; Murakawa M; Shiozawa M; Kobayashi S; Ueno M; Morimoto M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1129-S1134. PubMed ID: 30539858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of fine-needle aspiration in patients with resectable pancreatic cancer.
    Johnson DE; Pendurthi TK; Balshem AM; Ross E; Litwin S; Eisenberg BL; Hoffman JP
    Am Surg; 1997 Aug; 63(8):675-9; discussion 679-80. PubMed ID: 9247432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytology.
    Valletti M; Eshmuminov D; Gnecco N; Gutschow CA; Schneider PM; Lehmann K
    World J Surg Oncol; 2021 Aug; 19(1):245. PubMed ID: 34404403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of occult tumor cells obtained by peritoneal lavage in patients with resectable pancreatic cancer and no ascites: A systematic review.
    Steen W; Blom R; Busch O; Gerhards M; Besselink M; Dijk F; Festen S
    J Surg Oncol; 2016 Nov; 114(6):743-751. PubMed ID: 27642007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.